GOLD classifications and mortality in chronic obstructive pulmonary disease: The HUNT Study, Norway

Thorax

Volumn 68, Issue 10, 2013, Pages 914-921

  Leivseth, Linda ^a   Brumpton, Ben Michael ^a   Nilsen, Tom Ivar Lund ^a   Mai, Xiao Mei ^a   Johnsen, Roar ^a   Langhammer, Arnulf ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORWAY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SPIROMETRY;

COPD EPIDEMIOLOGY; COPD EXACERBATIONS;

AGED; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; NORWAY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; SURVIVAL ANALYSIS;

EID: 84884588810     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203270     Document Type: Article

References (30)

1. World Health Organization, 2012. http://www.who.int/en/ (accessed 26 Nov 2012).
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
3. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-65.
4. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD, 2013. http://www.goldcopd.org (accessed 4 Feb 2013).
5. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012;186:975-81.
6. Soriano JB, Alfageme I, Almagro P, et al. Distribution and prognostic validity of the new GOLD grading classification. Chest 2013;143:694-702.
7. Krokstad S, Langhammer A, Hveem K, et al. Cohort profile: the HUNT Study, Norway. Int J Epidemiol. Published Online First: 9 August 2012. doi:10.1093/ije/dys095
8. Leivseth L, Nilsen TI, Mai XM, et al. Lung function and anxiety in association with dyspnoea: the HUNT study. Respir Med 2012;106:1148-57.
9. Langhammer A, Johnsen R, Gulsvik A, et al. Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trøndelag Study. Eur Respir J 2001;18:770-9.
10. Langhammer A. Respiratory symptoms, lung function, and bone mineral density in a comprehensive population survey: The Nord-Trøndelag Health Study 1995-97, The Bronchial Obstruction in Nord-Trøndelag Study [PhD Thesis]. Norwegian University of Science and Technology, 2003.
11. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-36.
12. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-6.
13. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34:648-54.
14. Brogger JC, Bakke PS, Gulsvik A. Comparison of respiratory symptoms questionnaires. Int J Tuberc Lung Dis 2000;4:83-90.
15. Leivseth L, Nilsen TIL, Mai XM, et al. Lung function and respiratory symptoms in association with mortality: the HUNT Study. COPD Published Online First: 2013 (In press) doi:10.3109/15412555.2013.781578
16. Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax 1999;54:1119-38.
17. Langhammer A, Johnsen R, Holmen J, et al. Cigarette smoking gives more respiratory symptoms among women than among men. The Nord-Trøndelag Health Study (HUNT). J Epidemiol Community Health 2000;54:917-22.
18. Statistics Norway 2012. http://www.ssb.no/emner/02/02/10/dode/ tab-2012-04-19-02.html (accessed 17 Oct 2012).
19. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997;145:72-80.
20. Hernán MA, Robins JM. Causal Inference, 2012. http://www.hsph. harvard.edu/ faculty/miguel-hernan/files/hernanrobins-v1.10.19.pdf (accessed 11 Dec 2012).
21. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd edn. Philadelphia: Lippincott Williams & Wilkins, 2008.
22. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer 1977;35:1-39.
23. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
24. Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007;370:1829-39.
25. Morkedal B, Romundstad PR, Vatten LJ. Informativeness of indices of blood pressure, obesity and serum lipids in relation to ischaemic heart disease mortality: the HUNT-II study. Eur J Epidemiol 2011;26:457-61.
26. Mannino DM, Diaz-Guzman E, Buist S. Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study. Respir Res 2011;12:136.
27. Mannino DM, Doherty DE, Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006;100:115-22.
28. Ekberg-Aronsson M, Pehrsson K, Nilsson JA, et al. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005;6:98.
29. Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 2013;1:43-50.
30. Jones P, Adamek L, Nadeau G, et al. Comparisons of health status scores with MRC grades in a primary care COPD population: implications for the new GOLD 2011 classification. Eur Respir J. Published Online First: 20 December 2012. doi:10.1183/09031936.00125612